Valentina Caldera
Vercelli, 13100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment.
Journal: International journal of oncology
Published: February 02, 2015
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: June 16, 2014
Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Journal: Journal of pharmaceutical sciences
Published: January 31, 2014
Stem cell niches in glioblastoma: a neuropathological view.
Journal: BioMed research international
Published: January 20, 2014
Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.
Journal: The Journal of biological chemistry
Published: December 07, 2013
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
Journal: Neuro-oncology
Published: July 31, 2013
Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.
Journal: BioMed research international
Published: May 17, 2013
Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones.
Journal: Neuropathology and applied neurobiology
Published: March 25, 2013
Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.
Journal: Cellular and molecular life sciences : CMLS
Published: December 30, 2012
MGMT hypermethylation and MDR system in glioblastoma cancer stem cells.
Journal: Cancer genomics & proteomics
Published: July 17, 2012
REST controls self-renewal and tumorigenic competence of human glioblastoma cells.
Journal: PloS one
Published: January 23, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026